Trends and Dynamics of the Biosimilar Market across the EU, Latin America and Asia Pacific Regions
Listen now
Description
Following on from the previous podcast episode involving a discussion on the US biosimilar landscape, CBPartners’ experts explored trends and dynamics of the biosimilar market ex-USA – across the EU, Latin America and Asia, with a focus on:
Biosimilar availability and uptake in each region Key barriers limiting biosimilar approval and uptake Biosimilar manufacturer strategies to ensure successful launch
More Episodes
As the costs of biologic drugs increase, biosimilars have emerged as an appealing option for controlling costs and expanding access to treatment. While the uptake of biosimilars in the USA started off slowly, it has since gained a rapid pace.
In the first of a multi-part biosimilar series,...
Published 05/20/21
Published 03/05/21
Published 03/05/21
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
